Hemophilia Market Booming at 6.5% CAGR to Reach USD 22.50 Billion by 2031, Fueled by Prevalence of Hemophilia and Innovation
The Hemophilia Market was valued at USD 13.6 Billion in 2023 and is anticipated to reach USD 22.50 Billion by 2031. This translates to a remarkable compound annual growth rate (CAGR) of 6.5%...